Fri, December 1, 2017
Thu, November 30, 2017
Wed, November 29, 2017
Tue, November 28, 2017
Mon, November 27, 2017
Wed, November 22, 2017
Tue, November 21, 2017
Mon, November 20, 2017
Fri, November 17, 2017
Thu, November 16, 2017
Wed, November 15, 2017
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017

Derek Archila Maintained (URGN) at Buy with Increased Target to $51 on, Nov 15th, 2017


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-51-on-nov-15th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Oppenheimer, Maintained "UroGen Pharma Ltd." (URGN) at Buy with Increased Target from $32 to $51 on, Nov 15th, 2017.

Derek has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Derek's Rating of Hold.



This is the rating of the analyst that currently disagrees with Derek


  • Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $37 on, Monday, October 9th, 2017

Publication Contributing Sources